Holen Sie sich die Stockscreener-App
6.35
4.61%
0.28
Exicure Inc Aktie (XCUR) Neueste Nachrichten
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know - ts2.tech
Sangsangin investment sells Exicure (XCUR) shares worth $3.77 million By Investing.com - Investing.com Nigeria
Morning Market Movers: ASPC, ENVB, AFJK, JXG See Big Swings - RTTNews
Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels - MSN
Exicure’s Stunning Rise: What’s Fueling It? - StocksToTrade
Exicure Shares Surge 41% On Promising Phase 2 Data For Multiple Myeloma Drug - Nasdaq
Exicure Stock Soars 40% After Stem Cell Drug Helps Most Patients Hit Phase 2 Goal — Traders Call It ‘Cheap’ At Current Levels - Asianet Newsable
Exicure’s Risky Bet On Stem Cell Mobilization Pays Early Dividends - Finimize
Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga
Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms - ts2.tech
Exicure (XCUR) Stock: Biotech Soars on Promising Cancer Drug Data - parameter.io
ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma - Fierce Biotech
Dow Surges Over 100 Points; Campbell's Posts Upbeat Earnings - Benzinga
This BlackRock stock just rocketed 70% - Finbold
Exicure (XCUR) Stock: Biotech Shares Surge 140% on Cancer Drug Breakthrough - Blockonomi
Exicure Inc.: Is It a Bet Worth Taking? - timothysykes.com
Exicure Inc (XCUR) expanding its growth trajectory ahead - setenews.com
Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews
Morning Market Movers: ATMC, XCUR, VOR, ATMV See Big Swings - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Exicure Soars On Burixafor Data In Multiple Myeloma Trial - Nasdaq
Exicure Inc. (XCUR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
After-Hours Gainers: Exicure Tops List With 72% Jump, Wave Life And Assembly Biosciences Advance - Nasdaq
Exicure reports positive Phase 2 results for multiple myeloma therapy By Investing.com - Investing.com Nigeria
Exicure (XCUR) Sees Positive Phase 2 Trial Results for Burixafor in Multiple Myeloma - GuruFocus
Exicure presents topline data from burixafor combination trial - TipRanks
Exicure stock soars after positive Phase 2 data for multiple myeloma drug - Investing.com
Exicure, Inc. Reports Positive Phase 2 Trial Results for Burixafor in Hematopoietic Progenitor Cell Mobilization in Multiple Myeloma Patients - Quiver Quantitative
Exicure, Inc. Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma At 2025 Ash Annual Meeting - marketscreener.com
KOSDAQ firm The Technology buys Exicure Hitechron amid embezzlement probe, sparking insider trading suspicionsCHOSUNBIZ - Chosunbiz
Exicure Inc Trading Resumes - MSN
What analysts say about Exicure Inc stockPrice Action Analysis & Use Time as Your Investing Ally - earlytimes.in
Exicure Inc 2H0 Stock Analysis and ForecastMarket Sentiment Shifts & Free Exceptional Market Positioning - earlytimes.in
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Exicure Stock Surges 76%, With A 6-Day Winning Spree - Trefis
(XCUR) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
How Exicure Inc. (2H0) stock expands through international marketsGlobal Markets & Weekly Stock Breakout Alerts - Newser
How Exicure Inc. (2H0) stock correlates with oil marketsBond Market & AI Powered Market Trend Analysis - Newser
Will Exicure Inc. stock gain from strong economy2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
How Exicure Inc. (2H0) stock compares with tech leadersJuly 2025 Earnings & Long Hold Capital Preservation Tips - Newser
How Exicure Inc. (2H0) stock compares with market leadersQuarterly Profit Report & Growth Focused Entry Reports - Newser
Should I buy Exicure Inc. (2H0) stock before earnings seasonJuly 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Can Exicure Inc. (2H0) stock test all time highsSell Signal & Safe Entry Trade Reports - Newser
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Total assets of Exicure, Inc. – SWB:2H0 - TradingView
Exicure Redeems Convertible Bonds for Liquidity - MSN
Will Kanishk Steel Industries Limited Stock Continue to Outperform in YEARInsider Buying Signals & Free Tremendous Portfolio Expansion - earlytimes.in
What drives Exicure Inc stock priceInsider Buying Signals & Fast Profit Portfolio Plans - earlytimes.in
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Should I hold or sell Exicure Inc. stock in 2025Gap Down & Free AI Powered Buy and Sell Recommendations - newser.com
Will Exicure Inc. stock rally after Fed decisions2025 Earnings Surprises & Verified Technical Trade Signals - newser.com
Is Exicure Inc. stock a dividend growth opportunityWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):